Article
Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Atherosclerosis - 1 Jul 2017
Liu Ting Ting, Zeng Yi, Tang Kun, Chen XueMeng, Zhang Wei, Xu Xiao Le
Abstract excerpt
BACKGROUND AND AIMS: Dihydromyricetin, the most abundant flavonoid in Ampelopsis grossedentata, exerts numerous pharmacological activities, including anti-inflammatory, antioxidant, hepatoprotective, and lipid regulatory activities; however, its protective effect against atherosclerosis remains poorly understood. The aim of the present study was to evaluate the effects of dihydromyricetin on high fat diet...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
